Patents by Inventor Norbert Prenzel

Norbert Prenzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins
    Publication number: 20160009796
    Abstract: Provided herein are antigen binding proteins, e.g., human and/or monoclonal antibodies that have affinity for heparin-binding epidermal growth factor-like growth factor (HB-EGF) and neutralize the biological functions of this growth factor.
    Type: Application
    Filed: July 28, 2014
    Publication date: January 14, 2016
    Inventors: ROTHE MIKE, NORBERT PRENZEL, ERIC BORGES, THORE HETTMANN, ESTHER ZWICK-WALLASCH
  • Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins
    Publication number: 20150056211
    Abstract: Provided herein are antigen binding proteins, e.g., human and/or monoclonal antibodies that have affinity for heparin-binding epidermal growth factor-like growth factor (HB-EGF) and neutralize the biological functions of this growth factor.
    Type: Application
    Filed: July 28, 2014
    Publication date: February 26, 2015
    Inventors: ROTHE MIKE, NORBERT PRENZEL, ERIC BORGES, THORE HETTMANN, ESTHER ZWICK-WALLASCH
  • Heparin-binding epidermal growth factor-like growth factor binding proteins
    Patent number: 8828382
    Abstract: Provided herein are antigen binding proteins, e.g., human and/or monoclonal antibodies that have affinity for heparin-binding epidermal growth factor-like growth factor (HB-EGF) and neutralize the biological functions of this growth factor.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: September 9, 2014
    Assignees: U3 Pharma GmbH, Amgen Inc.
    Inventors: Mike Rothe, Norbert Prenzel, Eric Borges, Thore Hettmann, Esther Zwick-Wallasch, Orit Foord
  • Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins
    Publication number: 20110110956
    Abstract: Provided herein are antigen binding proteins, e.g., human and/or monoclonal antibodies that have affinity for heparin-binding epidermal growth factor-like growth factor (HB-EGF) and neutralize the biological functions of this growth factor.
    Type: Application
    Filed: September 26, 2008
    Publication date: May 12, 2011
    Applicants: AMGEN, INC., U3 PHARMA GMBH
    Inventors: Mike Rothe, Norbert Prenzel, Eric Borges, Thore Hettmann, Esther Zwick-Wallasch, Orit Foord
  • EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRES METALLOPROTEINASE CLEAVAGE OF proHB-EGF
    Publication number: 20100048684
    Abstract: The present invention relates to agents and methods for growth-factor receptor activation by modulating the G-protein mediated signal transduction pathway.
    Type: Application
    Filed: November 3, 2009
    Publication date: February 25, 2010
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Axel Ullrich, Norbert Prenzel, Esther Zwick-Wallasch, Henrik Daub